跳至主要内容
临床试验/NL-OMON54239
NL-OMON54239招募中不适用

Prospective Evaluation of Vestibular Schwannoma Irradiation - PEVI

eids Universitair Medisch Centrum0 个研究点目标入组 145 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
145

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - age of at least 18 years
  • - patient with vestibular schwannoma (radiologically proven diagnosis) with a
  • radiotherapy treatment indication or active surveillance for control group A
  • - able to provide written informed consent, as determined by the treating
  • - ability to comply with the protocol, including cognitive testing and imaging
  • - written informed consent

排除标准

  • - previous surgical excision or radiotherapy for vestibular schwannoma
  • - incapacitated adults
  • - contra-indication for MRI
  • - impaired kidney function (eGFR known to be under 30 mm/min)
  • - Gadolinium allergy
  • - any prior cranial radiotherapy or chemotherapy
  • - any psychological, familial, sociological or geographical condition
  • potentially hampering compliance with the study protocol and follow-up schedule
  • in the participating hospitals
  • - any serious medical condition that could interfere with follow-up
  • - severe aphasia, (functional) analphabetism or language barrier interfering
  • with assessing endpoints
  • - pregnancy, lactation or intention to become pregnant during the study, since
  • this is a contra-indication for undergoing Gadolinium-contrast enhanced MRI

研究者

相似试验

Prospective Evaluation of Vestibular Schwannoma... | 临床试验